Literature DB >> 8878443

Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.

W K Jones1, I L Grupp, T Doetschman, G Grupp, H Osinska, T E Hewett, G Boivin, J Gulick, W A Ng, J Robbins.   

Abstract

The alpha-myosin heavy chain (alpha-MyHC) is the major contractile protein expressed in the myocardium of adult mice. We have produced mice carrying a null mutation of alpha-MyHC by homologous recombination in murine ES cells. Homozygous null animals die between 11 and 12 d in utero of gross heart defects, while alpha-MyHC+/- heterozygotes survive and appear externally normal. The presence of a single functional alpha-MyHC+ allele in heterozygous animals results in reduced levels of the transcript and protein as well as fibrosis and alterations in sarcomeric structure. Examination of heart function using a working heart preparation revealed severe impairment of both contractility and relaxation in a subset of the alpha-MyHC+/- animals. Thus, two alpha-MyHC+ alleles are necessary for normal cardiac development, and hemizygosity for the normal allele can result in altered cardiac function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878443      PMCID: PMC507631          DOI: 10.1172/JCI118992

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  In situ freezing of embryonic stem cells in multiwell plates.

Authors:  S Y Chan; M J Evans
Journal:  Trends Genet       Date:  1991-03       Impact factor: 11.639

2.  Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.

Authors:  W A Ng; I L Grupp; A Subramaniam; J Robbins
Journal:  Circ Res       Date:  1991-06       Impact factor: 17.367

3.  Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells.

Authors:  M A Rudnicki; G Jackowski; L Saggin; M W McBurney
Journal:  Dev Biol       Date:  1990-04       Impact factor: 3.582

4.  Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles.

Authors:  C J Beall; M A Sepanski; E A Fyrberg
Journal:  Genes Dev       Date:  1989-02       Impact factor: 11.361

5.  All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner.

Authors:  S Izumo; B Nadal-Ginard; V Mahdavi
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

6.  Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro.

Authors:  J Robbins; J Gulick; A Sanchez; P Howles; T Doetschman
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

7.  Titin, myosin light chains and C-protein in the developing and failing human heart.

Authors:  I Morano; K Hädicke; S Grom; A Koch; R H Schwinger; M Böhm; S Bartel; E Erdmann; E G Krause
Journal:  J Mol Cell Cardiol       Date:  1994-03       Impact factor: 5.000

8.  Altered expression of titin and contractile proteins in failing human myocardium.

Authors:  S Hein; D Scholz; N Fujitani; H Rennollet; T Brand; A Friedl; J Schaper
Journal:  J Mol Cell Cardiol       Date:  1994-10       Impact factor: 5.000

9.  Developmental regulation of myosin gene expression in mouse cardiac muscle.

Authors:  G E Lyons; S Schiaffino; D Sassoon; P Barton; M Buckingham
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

10.  Ifm(2)2 is a myosin heavy chain allele that disrupts myofibrillar assembly only in the indirect flight muscle of Drosophila melanogaster.

Authors:  M Chun; S Falkenthal
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  71 in total

1.  Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology.

Authors:  J James; H Osinska; T E Hewett; T Kimball; R Klevitsky; S Witt; D G Hall; J Gulick; J Robbins
Journal:  Transgenic Res       Date:  1999-02       Impact factor: 2.788

2.  Protein kinase-A dependent phosphorylation of transcription enhancer factor-1 represses its DNA-binding activity but enhances its gene activation ability.

Authors:  M P Gupta; P Kogut; M Gupta
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

3.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice.

Authors:  D D D'Angelo; Y Sakata; J N Lorenz; G P Boivin; R A Walsh; S B Liggett; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 4.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

5.  Cardiac-specific NRAP overexpression causes right ventricular dysfunction in mice.

Authors:  Shajia Lu; Garland L Crawford; Justin Dore; Stasia A Anderson; Daryl Despres; Robert Horowits
Journal:  Exp Cell Res       Date:  2011-01-26       Impact factor: 3.905

Review 6.  Role of animal models in HCM research.

Authors:  Rhian Shephard; Christopher Semsarian
Journal:  J Cardiovasc Transl Res       Date:  2009-08-07       Impact factor: 4.132

7.  Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.

Authors:  M C Colbert; D G Hall; T R Kimball; S A Witt; J N Lorenz; M L Kirby; T E Hewett; R Klevitsky; J Robbins
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

8.  Gene therapy for inherited arrhythmias.

Authors:  Vassilios J Bezzerides; Maksymilian Prondzynski; Lucie Carrier; William T Pu
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

9.  Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.

Authors:  Shunsuke Kawamoto; Jerald P Flynn; Qun Shi; Sana W Sakr; Jun Luo; Margaret D Allen
Journal:  Tissue Eng Part A       Date:  2011-03-23       Impact factor: 3.845

10.  Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex.

Authors:  Hui-Hua Li; Vishram Kedar; Chunlian Zhang; Holly McDonough; Ranjana Arya; Da-Zhi Wang; Cam Patterson
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.